Literature DB >> 7920462

Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus.

J Tankovic1, J Duval, P Courvalin.   

Abstract

We have constructed a gyrA trans-complementation plasmid, pAT512, by cloning the wild-type gyrA gene of Staphylococcus aureus into the expression vector pAT392. Introduction by electrotransformation of pAT512 into a high-level fluoroquinolone resistant mutant of S. aureus (ciprofloxacin MIC = 16 micrograms ml-1) having a gyrA mutation which results in a Ser-84 to Leu substitution, reduced the MICs of norfloxacin and ciprofloxacin for the host of four- and eight-fold, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7920462     DOI: 10.1111/j.1574-695X.1994.tb00471.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

1.  Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin.

Authors:  C Bisognano; P E Vaudaux; D P Lew; E Y Ng; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin.

Authors:  C Bisognano; P Vaudaux; P Rohner; D P Lew; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene.

Authors:  J Tankovic; F Mahjoubi; P Courvalin; J Duval; R Leclerco
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.

Authors:  Danesh Moradigaravand; Christine J Boinett; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2016-07-18       Impact factor: 9.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.